Platelets and arachidonic acid metabolism in human and experimental hypercholesterolemia

E. Tremoli, S. Colli, P. Maderna, R. Paoletti

Research output: Contribution to journalArticle

Abstract

The reported platelet alterations support the concept that platelets may be determining factors in the occurrence of the thromboembolic complications and in the development of atheroclerosis in hypercholesterolemia. Such diseases, however, are multifactorial and platelets may directly or via their released products modulate the behavior of other cell systems, such as leucocytes, endothelial and smooth muscle cells. In particular studies on platelet-vessel wall interactions in different vascular beds, such as coronary and cerebral district, will contribute to the understanding of the basic mechanisms of platelet activation in the atherosclerotic disease.

Original languageEnglish
Pages (from-to)333-337
Number of pages5
JournalVasa - Journal of Vascular Diseases
Volume13
Issue number4
Publication statusPublished - 1984

Fingerprint

Hypercholesterolemia
Arachidonic Acid
Blood Platelets
Platelet Activation
Smooth Muscle Myocytes
Blood Vessels
Leukocytes

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Platelets and arachidonic acid metabolism in human and experimental hypercholesterolemia. / Tremoli, E.; Colli, S.; Maderna, P.; Paoletti, R.

In: Vasa - Journal of Vascular Diseases, Vol. 13, No. 4, 1984, p. 333-337.

Research output: Contribution to journalArticle

@article{297dd807587946f49e5433576251c650,
title = "Platelets and arachidonic acid metabolism in human and experimental hypercholesterolemia",
abstract = "The reported platelet alterations support the concept that platelets may be determining factors in the occurrence of the thromboembolic complications and in the development of atheroclerosis in hypercholesterolemia. Such diseases, however, are multifactorial and platelets may directly or via their released products modulate the behavior of other cell systems, such as leucocytes, endothelial and smooth muscle cells. In particular studies on platelet-vessel wall interactions in different vascular beds, such as coronary and cerebral district, will contribute to the understanding of the basic mechanisms of platelet activation in the atherosclerotic disease.",
author = "E. Tremoli and S. Colli and P. Maderna and R. Paoletti",
year = "1984",
language = "English",
volume = "13",
pages = "333--337",
journal = "Vasa - European Journal of Vascular Medicine",
issn = "0301-1526",
publisher = "Verlag Hans Huber",
number = "4",

}

TY - JOUR

T1 - Platelets and arachidonic acid metabolism in human and experimental hypercholesterolemia

AU - Tremoli, E.

AU - Colli, S.

AU - Maderna, P.

AU - Paoletti, R.

PY - 1984

Y1 - 1984

N2 - The reported platelet alterations support the concept that platelets may be determining factors in the occurrence of the thromboembolic complications and in the development of atheroclerosis in hypercholesterolemia. Such diseases, however, are multifactorial and platelets may directly or via their released products modulate the behavior of other cell systems, such as leucocytes, endothelial and smooth muscle cells. In particular studies on platelet-vessel wall interactions in different vascular beds, such as coronary and cerebral district, will contribute to the understanding of the basic mechanisms of platelet activation in the atherosclerotic disease.

AB - The reported platelet alterations support the concept that platelets may be determining factors in the occurrence of the thromboembolic complications and in the development of atheroclerosis in hypercholesterolemia. Such diseases, however, are multifactorial and platelets may directly or via their released products modulate the behavior of other cell systems, such as leucocytes, endothelial and smooth muscle cells. In particular studies on platelet-vessel wall interactions in different vascular beds, such as coronary and cerebral district, will contribute to the understanding of the basic mechanisms of platelet activation in the atherosclerotic disease.

UR - http://www.scopus.com/inward/record.url?scp=0021751360&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021751360&partnerID=8YFLogxK

M3 - Article

C2 - 6440376

AN - SCOPUS:0021751360

VL - 13

SP - 333

EP - 337

JO - Vasa - European Journal of Vascular Medicine

JF - Vasa - European Journal of Vascular Medicine

SN - 0301-1526

IS - 4

ER -